SCHEMBL2011637

SCHEMBL2011637

Cc1nc(C)c(C#N)cc1C#N

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TSHR P16473 1/20 0.39
ALDH1A1 P00352 4/20 0.38
GAA P10253 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
HSD17B10 Q99714 1/20 0.36
KDM5A P29375 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19674775 0.87 KDM4E (0.47) KDM4ESMN1; SMN2CYP1A2CYP2C9CYP2C19
SCHEMBL25986160 0.85 KDM4E (0.42) KDM4ESMN1; SMN2CYP1A2CYP2C9CYP2C19
SCHEMBL33526375 0.84 NPSR1 (0.59) KDM4ESMN1; SMN2CYP1A2CYP2C9CYP2C19
SCHEMBL21604801 0.84 KDM4E (0.41) KDM4ESMN1; SMN2CYP1A2CYP2C9CYP2C19
SCHEMBL18369275 0.84 CYP1A2 (0.42) KDM4ESMN1; SMN2CYP1A2CYP2C9CYP2C19
SCHEMBL12143428 0.84 KHK (0.44) KDM4ESMN1; SMN2CYP1A2CYP2C9CYP2C19
SCHEMBL810713 0.84 KDM4E (0.53) KDM4ESMN1; SMN2TSHRALDH1A1GAA
SCHEMBL16476943 0.80 KDM4E (0.39) KDM4ESMN1; SMN2CYP1A2CYP2C9CYP2C19
SCHEMBL20620010 0.77 NPSR1 (0.49) KDM4ESMN1; SMN2CYP1A2CYP2C9CYP2C19
SCHEMBL8192069 0.77 KDM4E (0.46) KDM4ESMN1; SMN2TSHRALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011067189-A2 CMET INHIBITORS FOR TREATING ENDOMETRIOSIS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-06-09 WO claimed
EP-2121608-A1 DIHYDROPYRIDINE DERIVATIVES USEFUL AS PROTEIN KINASE INHIBITORS Bayer Schering Pharma AG (DE) 2009-11-25 EP claimed
WO-2008071451-A1 DIHYDROPYRIDINE DERIVATIVES USEFUL AS PROTEIN KINASE INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-06-19 WO claimed
EP-2121608-B1 DIHYDROPYRIDINE DERIVATIVES USEFUL AS PROTEIN KINASE INHIBITORS BAYER IP GMBH (DE) 2012-11-14 EP disclosed